Tuesday, January 24, 2012

Identifying those likely to get Alzheimer's disease

Please Help Support Alzheimer's Research Today! 
Your Alzheimer's donation will help billions live without it.

(  early detection and effective therapy )
The team leader, Professor Cliff Abrahams, said treatments for the disease would probably be developed in the near future, but to be useful, they would need to be administered while the disease was in its early stages, before significant brain damage.
A blood test that could identify biomarkers for those at risk would contribute to an early diagnosis and aid treatment. "The expectation is that when such treatments do come on stream – and it is just a matter of time – we will want to be able to give people whatever treatment is developed as early as possible," said Abrahams. "It's agreed that the earlier you can diagnose, the better it will be."
Neuropsychological testing and clinical assessment were the current ways patients were diagnosed, but some of the tests were invasive and expensive. "The attraction of a blood test is simplicity and cost. It can be done in any center. You don't need to have access to sophisticated equipment."
Over the next two months, the team would recruit about 80 patients with Alzheimer's disease and take blood samples. Plasma molecules would then be screened using biochemical and molecular techniques to identify proteins or other biomarkers that characterise the disease. The predictive power would then be tested on archived blood samples from previous volunteers, some of whom had since developed Alzheimer's. Continue to readsanluisobispo.com


Weight management benefits of capsaicin



Capsaicin, the main pungent compound in hot peppers, and capsiates, non-pungent compounds in sweet peppers, show ‘modest’ weight management potential, says a new meta-analysis from Purdue. Read morenutraingredients-usa.com 

Погода в Беларуси


Posted YVN (AMYLOID @ PHOTO). 

No comments:

Post a Comment